CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Optiscan Imaging Ltd Company Snapshot
Optiscan Imaging Ltd. Optiscan Imaging Limited is engaged in the development and commercialization of confocal microscopes. The Company has two business segments: realisation (trading), and research and development. The realization (trading) segment comprises manufacturing and sales of confocal imaging products. The research and development segment's activities include design and development of new products and technologies, including related income from customers. The Company's products are Pentax ISC-1000 and Optiscan FIVE1. Pentax ISC-1000 product has adopted its technology in the management of Barrett's Oesophagus and the prevention of oesophageal adenocarcinoma (Barrett's cancer). The Optiscan FIVE1 is a fluorescence endomicroscope that has been designed for in vivo investigations of animal tissues. The FIVE1 enables a range of animal imaging studies in different organ systems.

Sales Analysis. Optiscan Imaging Ltd reported sales of A$1.19 million (US$839.12 thousand) for the fiscal year ending June of 2020. This represents an increase of 13.2% versus 2019, when the company's sales were A$1.05 million. Despite this increase, sales are still well below the level achieved in 2018, when Optiscan Imaging Ltd reported sales of A$2.20 million.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Optiscan Imaging Ltd
  Stock Performance Chart for Optiscan Imaging Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (10/23/2020): .11
(Figures in Australian Dollars)
1 Week -4.3%   13 Weeks -15.4%  
4 Weeks 144.4%   52 Weeks 182.1%  
 
Optiscan Imaging Ltd Key Data:
  Ticker: OIL Country: Australia
  Exchanges: OTC BLN ASX Major Industry: Health Care Equipment & Services
    Sub Industry: Optical Instruments & Lenses
  2020 Sales 1,190,712
(Year Ending Jan 2021).
Employees: 8
  Currency: Australian Dollars Market Cap: 52,555,668
  Fiscal Yr Ends: June Shares Outstanding: 477,778,800
  Share Type: Ordinary Closely Held Shares: 201,183,546
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.